| [1] |
Vivarelli M, Gibson K, Sinha A, et al. Childhood nephrotic syndrome[J/OL]. Lancet, 2023, 402(10404): 809-824. https://doi.org/10.1016/S0140-6736(23)01051-6.
|
| [2] |
Watts AJB, Keller KH, Lerner G, et al. Discovery of autoantibodies targeting Nephrin in minimal change disease supports a novel autoimmune etiology[J/OL]. J Am Soc Nephrol, 2022, 33(1): 238-252. https://doi.org/10.1681/ASN.2021060794.
|
| [3] |
Horinouchi T, Nozu K, Iijima K. Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies[J/OL]. Clin Exp Nephrol, 2025, 29(5): 534-540. https://doi.org/10.1007/s10157-025-02645-4.
|
| [4] |
Shu Y, Huang J, Jiang L, et al. Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis[J/OL]. Kidney Int, 2025, 108(3): 433-444. https://doi.org/10.1016/j.kint.2025.02.028.
|
| [5] |
Liu P, Liu S, Dalal V, et al. Evaluation of methodologies in anti-nephrin autoantibody detection[J/OL]. Kidney Int, 2025, 108(3): 485-490. https://doi.org/10.1016/j.kint.2025.05.018.
|
| [6] |
Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome[J/OL]. Pediatr Nephrol, 2023, 38(3): 877-919. https://doi.org/10.1007/s00467-022-05739-3.
|
| [7] |
Floege J, Gibson KL, Vivarelli M, et al. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J/OL]. Kidney Int, 2025, 107(5S): S241-S289. https://doi.org/10.1016/j.kint.2024.11.007.
|
| [8] |
中华医学会儿科学分会肾脏学组, 中华儿科杂志编辑委员会. 中国儿童慢性肾脏病早期筛查临床实践指南(2021版)[J/OL]. 中华儿科杂志, 2022, 60(9): 858-868. https://doi.org/10.3760/cma.j.cn112140-20220714-00647.
|
|
Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Clinical practice guideline for early screening of pediatric chronic kidney disease in China (version 2021)[J]. Zhonghua Erke Zazhi, 2022, 60(9):858-868. https://doi.org/10.3760/cma.j.cn112140-20220714-00647.
|
| [9] |
中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)[J/OL]. 中华儿科杂志, 2017, 55(10): 729-734. https://doi.org/10.3760/cma.j.issn.0578-1310.2017.10.003.
|
|
Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association. Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome in children (2016)[J]. Zhonghua Erke Zazhi, 2017, 55(10): 729-734. https://doi.org/10.3760/cma.j.issn.0578-1310.2017.10.003.
|
| [10] |
Aoyagi J, Kanai T, Ito T, et al. Glucocorticoid effects on bone strength in children with renal diseases[J/OL]. Nephrology (Carlton), 2021, 26(2): 119-125. https://doi.org/10.1111/nep.13832.
|
| [11] |
唐毓贤, 龚粤婷, 聂晓晶. 儿童原发性肾病综合征激素治疗反应预测因子的研究进展[J/OL]. 中华儿科杂志, 2023, 61(12) : 1144-1147. https://doi.org/10.3760/cma.j.cn112140-20230824-00126.
|
|
Tang YX, Gong YT, Nie XJ. Research progress on predictors of hormone efficacy in children with primary nephrotic syndrome[J]. Zhonghua Erke Zazhi, 2023, 61(12): 1144-1147. https://doi.org/10.3760/cma.j.cn112140-20230824-00126.
|
| [12] |
Hengel FE, Dehde S, Lassé M, et al. Autoantibodies targeting Nephrin in podocytopathies[J/OL]. N Engl J Med, 2024, 391(5): 422-433. https://doi.org/10.1056/NEJMoa2314471.
|
| [13] |
Hengel FE, Dehde S, Yilmaz A, et al. Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy[J/OL]. Kidney Int, 2025, 107(6): 1099-1103. https://doi.org/10.1016/j.kint.2025.01.019.
|
| [14] |
Chen Q, Chen S, Ye Q, et al. Anti-nephrin antibody: a potential biomarker of minimal change disease[J/OL]. Clin Kidney J, 2025, 18(3): sfaf012. https://doi.org/10.1093/ckj/sfaf012.
|
| [15] |
上海市医学会检验医学分会. 新型冠状病毒核酸和抗体检测临床应用专家共识[J/OL]. 国际检验医学杂志, 2020, 41(14): 1665-1669. https://doi.org/10.3969/j.issn.1673-4130.2020.14.001.
|
|
Shanghai Medical Association Laboratory Medicine Branch. Expert consensus on the clinical application of nucleic acid and antibody detection for novel coronavirus[J]. Guoji Jianyan Yixue Zazhi, 2020, 41(14): 1665-1669. https://doi.org/10.3969/j.issn.1673-4130.2020.14.001.
|
| [16] |
Huergo LF, Selim KA, Conzentino MS, et al. Magnetic bead-based immunoassay allows rapid, inexpensive, and quantitative detection of human SARS-CoV-2 antibodies[J/OL]. ACS Sens, 2021, 6(3): 703-708. https://doi.org/10.1021/acssensors.0c02544.
|
| [17] |
中国医疗保健国际交流促进会基层检验技术标准化分会. 基层医疗机构开展自身抗体检测与应用的专家共识[J/OL]. 中华预防医学杂志, 2024, 58(12): 1835-1852. https://doi.org/10.3760/cma.j.cn112150-20240907-00715.
|
|
Grassroots Inspection Technology Standardization Branch of China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on autoantibody detection and application in primary healthcare institutions[J/OL]. Zhonghua Yufangyixue Zazhi, 2024, 58(12) : 1835-1852. https://doi.org/10.3760/cma.j.cn112150-20240907-00715.
|
| [18] |
Gao F, Zhang Y, Lv J, et al. How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases[J/OL]. Ann Transl Med, 2023, 11(7): 281. https://doi.org/10.21037/atm-21-3072.
|
| [19] |
Molina RD, Conzatti LP, Da Silva APB, et al. Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays[J/OL]. Mult Scler Relat Disord, 2020, 38: 101858. https://doi.org/10.1016/j.msard.2019.101858.
|
| [20] |
Dähnrich C, Saschenbrecker S, Gunnarsson I, et al. Development of a standardized chemiluminescence immunoassay for the detection of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy[J/OL]. Kidney Int Rep, 2020, 5(2): 182-188. https://doi.org/10.1016/j.ekir.2019.11.008.
|